Acute Mesenteric Ischemia Management (ESVS 2017)
Acute Mesenteric Ischemia Management (ESVS 2017): Suspected Acute Mesenteric Ischemia → Clinical Recognition - High Index of Suspicion → Laboratory Stud...
Interactive Decision Tree
Algorithm Steps
- ▶Start
Suspected Acute Mesenteric Ischemia
Severe abdominal pain out of proportion to exam, especially with vascular/cardiac history
- ●Action
Clinical Recognition - High Index of Suspicion
Classic presentation often absent
- Sudden severe abdominal pain (80%)
- Pain out of proportion to physical exam
- Risk factors: AF, recent MI, CHF, atherosclerosis, hypercoagulable
- GI emptying (vomiting, diarrhea early)
- Peritonitis = late sign (bowel necrosis)
- ●Action
Laboratory Studies
Supportive but not diagnostic
- Lactate (elevated but non-specific)
- D-dimer (elevated in most cases)
- WBC (often elevated)
- Metabolic acidosis (late)
- Normal labs do NOT rule out AMI
- ◆Decision
AMI Subtype
Determines treatment approach
- Arterial embolism (~50%): AF, abrupt onset
- Arterial thrombosis (~25%): atherosclerosis, subacute
- MVT (~10%): hypercoagulable, portal HTN
- NOMI (~15%): hypoperfusion, vasoconstrictors
- ●Action
Immediate Resuscitation
Start in parallel with workup
- IV fluids - aggressive resuscitation
- Correct acidosis/electrolytes
- Broad-spectrum antibiotics
- Anticoagulation (UFH) unless contraindicated
- NG decompression
- Avoid vasopressors if possible (worsen ischemia)
- ◆Decision
Signs of Bowel Necrosis/Peritonitis?
Peritoneal signs, free air, pneumatosis
- ⚠Warning
⚠️ Emergent Laparotomy
Necrotic bowel requires surgical resection
- Resect non-viable bowel
- Revascularization (embolectomy, bypass)
- Second-look laparotomy at 24-48h
- Damage control if unstable
- Mortality 50-80%
- ●Action
Post-Treatment Care
ICU monitoring, nutrition, complications
- ICU monitoring
- Second-look surgery if needed
- Short bowel syndrome risk if extensive resection
- Long-term anticoagulation
- Address underlying cause (AF, hypercoagulable workup)
- ✓Outcome
Survival
Early diagnosis critical - overall mortality 50-80%
- ✓Outcome
Short Bowel Syndrome
If extensive resection required - may need long-term TPN
- ●Action
Endovascular/Hybrid Approach
If no peritonitis and viable bowel
- Catheter-directed thrombolysis
- Mechanical thrombectomy
- Angioplasty + stenting
- May combine with laparoscopy to assess bowel
- Consider surgical backup
- ●Action
MVT-Specific Treatment
Anticoagulation is primary therapy
- Systemic anticoagulation (UFH → LMWH/warfarin/DOAC)
- Duration: 6+ months (often lifelong)
- Catheter-directed thrombolysis if progressing
- Surgery only if bowel necrosis
- ●Action
NOMI Treatment
Non-occlusive mesenteric ischemia
- Treat underlying cause (shock, CHF)
- Discontinue vasoconstrictors if possible
- Intra-arterial papaverine/vasodilators
- Optimize cardiac output
- Surgery if bowel necrosis develops
- ●Action
CT Angiography (CTA)
Gold standard - obtain URGENTLY
- Arterial + portal venous phase
- Sensitivity/specificity >95%
- Shows: SMA occlusion, bowel wall changes, pneumatosis
- MVT: venous thrombus, bowel edema
- Do NOT delay for other studies
Guideline Source
ESVS 2017 Clinical Practice Guidelines on the Management of Acute Mesenteric Ischaemia
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- High mortality rate even with treatment (50-80%)
- Time-sensitive - requires rapid diagnosis
- CT angiography is gold standard but interpretation requires expertise
- Treatment approach depends on local surgical/IR expertise
- NOMI treatment differs from occlusive disease
Applicable Regions
EU: ESVS 2017 is current standard
US: Similar management principles as European guidelines
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Calculator
Glasgow-Blatchford Bleeding Score
Upper GI bleed risk stratification and need for intervention
Compare
AttendMe.ai vs UpToDate
See how this pathway workflow compares against UpToDate.
Commercial
Start free
Run the pathway in a live AttendMe account with citations and tracked usage.
Related Resources
Frequently Asked Questions
What is the Acute Mesenteric Ischemia Management (ESVS 2017)?
The Acute Mesenteric Ischemia Management (ESVS 2017) is a emergency clinical algorithm for Gastroenterology. It provides a structured decision tree to guide clinical decision-making, based on ESVS 2017 Clinical Practice Guidelines on the Management of Acute Mesenteric Ischaemia.
What guideline is the Acute Mesenteric Ischemia Management (ESVS 2017) based on?
This algorithm is based on ESVS 2017 Clinical Practice Guidelines on the Management of Acute Mesenteric Ischaemia (DOI: 10.1016/j.ejvs.2017.01.010).
What are the limitations of the Acute Mesenteric Ischemia Management (ESVS 2017)?
Known limitations include: High mortality rate even with treatment (50-80%); Time-sensitive - requires rapid diagnosis; CT angiography is gold standard but interpretation requires expertise; Treatment approach depends on local surgical/IR expertise; NOMI treatment differs from occlusive disease. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Acute Mesenteric Ischemia Management (ESVS 2017) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free